Type 2 diabetes mellitus as a predictor of severe outcomes in COVID-19 — a systematic review and meta-analyses

Detalles Bibliográficos
Parent link:BMC Infectious Diseases.— .— New York: BioMed Central (Springer Nature)
Vol. 25.— 2025.— Article number 719, 22 p.
Otros Autores: Babatunde F. Fatoke, Lal Hui Amrit, Saqib M. Muhammad, Vashisth M. Mrinal, Olaide A. S. Aremu Stephen, Aremu D. O. Dorcas Oluwakemi, Aremu D. B. Deborah Bukola
Sumario:Title screen
The COVID-19 pandemic has posed significant challenges to global health, with type 2 diabetes mellitus (T2DM) emerging as a key risk factor for adverse outcomes. This study systematically reviews and quantifies the association between T2DM and COVID-19 outcomes, including mortality, severity, and need for mechanical ventilation
Текстовый файл
Lenguaje:inglés
Publicado: 2025
Materias:
Acceso en línea:https://doi.org/10.1186/s12879-025-11089-w
Formato: Electrónico Capítulo de libro
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=682958

Ejemplares similares